These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17096029)

  • 1. Gene therapy targeting to tumor endothelium.
    Bazan-Peregrino M; Seymour LW; Harris AL
    Cancer Gene Ther; 2007 Feb; 14(2):117-27. PubMed ID: 17096029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of antiangiogenic agents for cancer gene therapy.
    Dickson PV; Nathwani AC; Davidoff AM
    Technol Cancer Res Treat; 2005 Aug; 4(4):331-41. PubMed ID: 16029054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
    Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
    Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
    Park J; Singha K; Son S; Kim J; Namgung R; Yun CO; Kim WJ
    Cancer Gene Ther; 2012 Nov; 19(11):741-8. PubMed ID: 23018622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-based targeting of the tumor vasculature.
    Schliemann C; Neri D
    Biochim Biophys Acta; 2007 Dec; 1776(2):175-92. PubMed ID: 17920773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological aspects of targeting cancer gene therapy to endothelial cells.
    Sedlacek HH
    Crit Rev Oncol Hematol; 2001 Mar; 37(3):169-215. PubMed ID: 11248576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor vascular targeting therapy with viral vectors.
    Liu Y; Deisseroth A
    Blood; 2006 Apr; 107(8):3027-33. PubMed ID: 16373660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor angiogenesis with gene therapy.
    Chen QR; Zhang L; Gasper W; Mixson AJ
    Mol Genet Metab; 2001; 74(1-2):120-7. PubMed ID: 11592809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-directed cancer gene therapy to angiogenic vasculature.
    Driessen WHP; Ozawa MG; Arap W; Pasqualini R
    Adv Genet; 2009; 67():103-121. PubMed ID: 19914451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and future directions for angiogenesis-based cancer therapies.
    Scappaticci FA
    J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and vascular targeting of solid tumors.
    Brekken RA; Thorpe PE
    Anticancer Res; 2001; 21(6B):4221-9. PubMed ID: 11908675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor vasculature with homing peptides from phage display.
    Ruoslahti E
    Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?
    Denekamp J; Daşu A; Waites A
    Adv Enzyme Regul; 1998; 38():281-99. PubMed ID: 9762359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
    Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
    Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
    Ding Y; Li S; Nie G
    Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
    Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
    Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors.
    Ferrari N; Glod J; Lee J; Kobiler D; Fine HA
    Gene Ther; 2003 Apr; 10(8):647-56. PubMed ID: 12692593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy vector design strategies for the treatment of cancer.
    Dong JY; Woraratanadharm J
    Future Oncol; 2005 Jun; 1(3):361-73. PubMed ID: 16556010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.